Products Description

 

Product name

Diabinil

Composition

 

Each tablet contains :

Glibenclamide 5 mg.

 

 Indications

 

- Diabinil (glibenclamide) increase risk of hypoglycemia if concomitantly administered with NSAIDs chloramphenicol guanethidine, monoaminoxidase inhibitors, probenecid, salicylates, beta-adrenergic blocking agents and sulfonamides.

- Diabinil (glibenclamide) increased hyperglycemia if concomitantly administered with corticosteroids, phenothiazines, nicotinic acid, sympathomimmetics, calcium channel blockers, phenytoin, thiazide and other diuretics, isoniazid, thyroid hormones, oral contraceptives and estrogens.

 

Dosage & Administration

 

- Diabinil (glibenclamide) increase risk of hypoglycemia if concomitantly administered with NSAIDs chloramphenicol guanethidine, monoaminoxidase inhibitors, probenecid, salicylates, beta-adrenergic blocking agents and sulfonamides.

- Diabinil (glibenclamide) increased hyperglycemia if concomitantly administered with corticosteroids, phenothiazines, nicotinic acid, sympathomimmetics, calcium channel blockers, phenytoin, thiazide and other diuretics, isoniazid, thyroid hormones, oral contraceptives and estrogens.

 

Presentation

 

Diabinil 5 mg pack of 2 blister X 10 tablets.

Hospital packs of different size.

 

 

Copyright 2008 biopharm-ye. All rights reserved